Dovpo Released Samdwich RDA in Collaboration with Across Vape

Sep.05.2022

The Samdwich RDA, a new vaping device by Dovpo and Across Vape, features a thick steel body with innovative design.

Dovpo has partnered with Across Vape to launch their latest e-cigarette product, the Samdwich RDA, in Russia.

The source of the Sandwich RDA is Viva la Cloud.

On August 31, 2022, Dovpo launched the Sandwich RDA on their Facebook page. This device boasts a sturdy steel body and features a few innovative design elements. The top includes a rotating cover with a large edge and several different air intake options with varying hole structures cut into the inner wall of the cover. The base is adorned with bold engravings and includes a pair of cylindrical supports.

Product Features:

Dimensions of the product are 31.9 mm in height and 22 mm in diameter. It comes with a spiral base that can adjust the airflow. The price is 2,100 rubles (approximately $35).

Statement

This article was compiled from third-party information and is intended solely for industry exchange and learning purposes.

This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's contents. The translation of this article is intended only for industry communication and research purposes.

Due to limitations in translation ability, the translated article may not express the original text accurately. Please refer to the original text for accuracy.

2FIRSTS fully aligns its statements and positions with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign-related affairs.

The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.

#Europe #Legislation #Alemania

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Illegal Disposable Vapes Still Sold in Nottingham Six Months After UK Ban: LBC Investigation

According to LBC, a follow-up investigation in Nottingham found that four out of 14 shops visited still sold illegal disposable vapes, six months after the UK Government’s ban took effect. Although fewer retailers appeared to be offering banned products compared with an earlier visit, illegal vapes remain available despite ongoing enforcement efforts.

Dec.03 by 2FIRSTS.ai

California Federal Judge Signals Likely Class Certification in Juul–Altria Antitrust Case

U.S. District Judge William Orrick of the Northern District of California indicated on Friday that he will likely certify classes of direct and indirect purchasers accusing e-cigarette makers Juul Labs Inc. and former rival Altria Group Inc. of conspiring to limit product variety and violate antitrust laws.

Oct.20 by 2FIRSTS.ai

Bangladesh High Court Questions Legality of BEZA’s Approval for Philip Morris Nicotine Pouch Factory

The High Court in Bangladesh has asked government bodies to explain why the approval granted to Philip Morris to establish a nicotine pouch factory should not be deemed illegal. Petitioners argue the decision contradicts existing policies and a 2016 Appellate Division ruling that restricts new tobacco-related enterprises. Authorities have ten days to respond.

Nov.20 by 2FIRSTS.ai

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai